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Acquired immunodeficiency syndrome (AIDS) has become rates, cardiac lesions other than those due to opportunistic 
an increasingly important health problem worldwide. This infections or malignancy should be seen. 
review focuses on its cardiac complications. The key ele- Cardiac complications are described in terms of the 
ments in the clinical syndrome are the opportunistic infec- pathologic lesions, the clinical manifestations that ensue as 
tions and the cancer that occur as a by-product of the a result of the pathologic lesions and the cardiac abnormal- 
immunodeficiency process. However, as early diagnosis, ities that can occur from administration of the various 
aggressive therapy and better supportive care become therapeutic agents in the syndrome. 
increasingly available, with consequently longer survival (J Am Co11 Cardiol1989;13:1144-54) 
Progressive dysfunction of multiple organ systems occurs in 
acquired immunodeficiency syndrome (AIDS). The pulmo- 
nary, gastrointestinal and neurologic systems have been the 
principal targets, but it appears that the heart, too, should be 
part of the total involvement. The early necropsy studies 
failed to indicate the presence of cardiac lesions that had any 
degree of clinical significance. However, cardiac lesions 
currently being reported are quite diverse and reflect the 
various pathologic pathways of cardiac involvement in 
AIDS. Lesions other than those due to opportunistic infec- 
tions or malignancy should be seen as early diagnosis, 
aggressive therapy and better supportive care become in- 
creasingly available and survival time lengthens. Moreover, 
the rapidly escalating prevalence of AIDS itself mandates 
awareness of cardiac involvement in this disease, since it is 
most likely that cardiac complications of AIDS will be 
encountered with increasing frequency. In this review, these 
complications will be described in terms of the pathologic 
lesions, the clinical manifestations that ensue as a result of 
the pathologic lesions and the cardiac abnormalities that can 
occur from administration of the various therapeutic agents 
used in the management of AIDS. 
There have been several necropsy studies (l-5) describ- 
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ing the cardiac lesions in AIDS. The causes of death in these 
initial studies were ascribed to a variety of opportunistic 
infections and neoplasms. Survival time from initial diagno- 
sis to death varied from 2 weeks to 22 months. The striking 
feature in these studies was the failure of the necropsy 
findings to indicate that the presence of the cardiac lesions 
had clinical significance. Hui et al. (1) were the first to point 
out the ‘anomalous patterns of infection at postmortem 
examination, such as cytomegalovirus infection without 
evidence of inflammation and acid-fast infection without 
granuloma formation. The various cardiac lesions that have 
been described in AIDS are listed in Table 1. 
Myocarditis 
Clinical manifestations of myocarditis are dependent on 
the severity of the inflammatory process and, if focal in type, 
on the ldcation of the lesion. For example, James et al. (6) 
described the occurrence of conduction disturbances when 
focal lesions involve the His bundle or its branches. Clinical 
manifestations may be completely nonexistent, obscured by 
the systemic manifestations of the underlying syndrome or 
strikinglk severe with full-blown congestive heart failure or 
disablini arrhythmias, or both (7). 
The domplete etiologic spectrum of myocarditis in AIDS 
has not, as yet, been completely delineated. There appear to 
be many etiologic factors acting separately or in combina- 
tion. An infectious factor due to opportunistic infection is 
certainly well documented. 
Oppktunistic infections. The list of opportunistic infec- 
tious agents (Table 1) that have been identified in AIDS- 
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Table 1. Cardiac Lesions in AIDS 
Myocarditis 
Opportunistic infections 
Pnetrm0~ysli.t coritrii 
Mw~hac~lerirrnf tdwrc~dosis 
M~cohac,rc~riro,~ cil,i,cm-irflrtr~ellrrlrlrr 
C,.ky‘v”‘~“i”~1~.Y tlrc~fw/llo,l.\ 
A.qxqi//rrs ,firmi,qofu\ 
Contlido dhic cuu 
Hi.~fop/o.mKr c~crp’rt/ritrm 
Cfuidioid~s iv7rrriri.t 
To.rop/rr~rw yordii 
Herpes simplex 
Viral agent5 
C\tomegaloviru\ 
Human immunodeticiency virus (HIV) 
Lymphocvtic myocarditis 
Noninflammatory mhocardial necrosis 
Mlcrovascular cpabm’? 
Endocarditis 
Marantic endocarditk (nonbacterial thrombotic endocarditis) 
Healed bacterial endocarditi> 
A rpcvyillo.~ endocardltl3 
Pericarditis 
Infectious 
Tuberculous 
Herpe\ Gmplex 
Noninfectious 
Pericardial effusion 
Cardiomegal) 
Right ventricular hypertrophy or ddation 
Biventricular dilation (congestive cardiomyopathy) 
Vaszular lesions 
Arteriopathy 
Myocardlal infarction 
Malignanq 
Kaposi.5 sarcoma 
Malignant lymphoma 
TOXIC lewns 
Drug-induced 
Drug5 used in combating opportunistic infections 
Anti-HIV drugs 
associated myocarditis is by no means complete, since 
further studies will almost surely identify other agents. 
However, despite the broad range of infectious agents to 
which patients with AIDS are potentially and theoretically 
susceptible, most of the studies incriminate a relatively 
uniform and characteristic pattern of such agents (8) (Table 
2). Multiple infections in combination are also frequent 
(9,lO). Although current therapy has prolonged survival, its 
primary impact on the infectious aspect of AIDS (that is, 
regarding the opportunistic agents) has been to shift the type 
of infections from the potentially treatable to the untreatable 
category. This shift will have some bearing on the ultimate 
outcome of AIDS-associated myocarditis due to such infec- 
tious agents. 
Among the vcrrious opportunistic infectious regents, some 
hnl*e come under more careful scruriny. Examples of these 
are Toxoplastna gondii. Myobucteriutn tuberculosis, cryp- 
tococcal myocarditis and cytomegalovirus infection. Lewis 
et al. (I I) reported on two patients with acute myocarditis 
due to Cryptococcus neoformans. Although these patients 
had hidespread cryptococcal infection. neither had clinical 
evidence of heart disease. 
Toxoplasma gondii \~YJS isolatedjk~m mice infected with 
ccrrdiac tissue from one patient (12). This same patient’s 
cardiac tissue showed nonspecific wavy changes in the 
myocardial fibers, but no Toxoplastnm cysts were identified 
on histologic section. Toxoplasmrr myocarditis could repre- 
sent a reactivation of toxoplasmosis as a result of the 
deficient immune response in AIDS rather than a new 
opportunistic infection (12). Although this is a difficult ques- 
tion to resolve, the answer really does not matter from a 
purely therapeutic point of view, since management of the 
infection itself is not altered. 
Otw worrld expect Mycobacterium tuberculosis to be a 
ljery comtnott agent because. in the presence of defective 
cell-mediated immune systems, tuberculous lesions can dis- 
seminate widely. However, tuberculosis has not been a 
conspicuous feature of AIDS except in Haitians. in whom 
this disease is frequent to begin with (13). Pitchenik et al. 
(14) reported a high (5070) incidence of tuberculosis in their 
survey of 20 heterosexual Haitian residents in Miami. How- 
ever, even though myocarditis with tuberculous involvement 
has been described. it is not usual among the present studies. 
More usual is the occurrence of pericardial tuberculosis as 
part of a widely disseminated process. 
Role of viral agents. The role of viral agents, such as 
cytomegalovirus as well as human immunodeficiency virus 
itself. should also be seriously considered. Human immuno- 
deficiency virus was isolated in culture from an endomyo- 
cardial biopsy specimen from a patient with AIDS with 
congestive cardiomyopathy (15). Myocardial involvement in 
cytomegalovirus infection has been previously reported (16), 
but is rarely seen in immunosuppressed patients. Although 
cytomegalovirus infection has been reported as a common 
histologic finding in patients with AIDS, the typical owl’s 
eye inclusion bodies have only rarely been found within the 
myocardium itself (1,17-22). Because it is well known that 
cytomegalovirus infections can cause tissue necrosis without 
associated inflammatory changes, it is still possible that 
cytomegalovirus or other viruses, including human immuno- 
deficiency virus. were the responsible agents in those nec- 
ropsy studies of patients with AIDS in whom myocardial 
necrosis without inflammation was seen (21,22). 
Human immunodejiciency virus tnq damage the 
trzonocytes either by direct infection with ultimate cytolysis 
or by “innocent bystander destruction.” as proposed by Ho 
et al. (20) in their explanation for the presence of neuroglial 
cell damage in AIDS-associated subacute encephalitis. In 
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Table 2. Infections in AIDS 
Microorganisms 
Protozoa 
Pneumocyslis carinii 
Toxoplasma gondii 
Cryptosporidium species 
Entamoeba histolytica 
Isospora belli 
Giardia lamblia 
Fungi 
Candida species 
Ctyptococcus neoformans 
Histoplasma capsulltum 
Coccidioides immitis 
Bacteria 
Mycobacterium avium intracellulare 
Mycobacierium tuberculosis 
Nocardia asteroides 
Viruses 
Cytomegalovirus 
Herpes simplex viruses 
Epstein-Barr virus 
Common Locations 
Lungs 
CNS. eyes, heart 
GI tract 
GI tract 
Cl tract 
Gl tract 
Oropharynx, esophagus, bladder, 
lungs 
CNS, lungs, lymph nodes, bone 
marrow, blood, urine 
Lymph nodes, bone marrow, lungs 
Lungs, lymph nodes, skin 
Lymph nodes, bone marrow, lungs, 
skin, blood, spleen, liver 
Same 
Lungs 
Disseminated (lungs, adrenals, eyes, 
CNS, liver, kidneys, intestinal 
tract, lymph nodes, blood); 
predilection for endothelial cells 
Mucocutaneous 
Uncertain 
Polyoma viruses CNS 
Common Clinical Manifestations 
Pneumocystis pneumonia 
CNS mass; chorioretinitis 
Diarrhea 
Diarrhea 
Diarrhea 
Diarrhea 
Thrush, esophagitis, cystitis, pneumonia 
Meningitis, pneumonia, dissemination 
Dissemination 
Dissemination 
Lymphadenitis, pancytopenia, pneumonia, 
dissemination 
Same 
Pneumonia 
Pneumonia, chorioretinitis, encephalitis, 
hepatitis, esophagitis, intestinal tract, 
enteritis, colitis, adrenal insufficiency 
Ulcerative mucocutaneous lesions 
Uncertain, Epstein-Barr-positive Burkitt’s 
lymphoma 
Pro.eressive multifocal leukencephalopathy 
Poxvirus Mucocutaneous Molluscum contagiosum 
Reproduced with permission from Cheryl M, Reichert MD. Infections in AIDS. 1983;112:359. CNS = central nervous system; GI = gastrointestinal. 
this mechanism, as the human immunodeficiency virus rep- 
licates itself within interstitial lymphocytes and macro- 
phages, certain enzymes are released that are toxic to the 
monocytes. The application of nucleic acid probes for hu- 
man immunodeficiency virus, cytomegalovirus and other 
opportunistic viral agents may help clarify the role of viruses 
in AIDS-associated myocarditis. 
Lymphocytic myocarditis. In a retrospective study of 71 
patients who died from AIDS, Anderson et al. (23) con- 
cluded that myocarditis is a frequent finding at autopsy. At 
least 37 cases of myocarditis were found in their series. In 
the majority of these patients, however, the etiology re- 
mained idiopathic. However, in seven cases, viral, proto- 
zoan, bacterial, fungal and myocardial opportunistic patho- 
gens were present. The myocarditis in their series was 
described as being usually focal and mild, with a mononu- 
clear infiltrate. The mild degree of inflammatory response 
seen in their series could possibly be the result of the marked 
cell-mediated immune deficiency in AIDS. 
Roldan et al. (24) reported a similar high incidence of 
myocarditis. Two histologic patterns were seen: 1) a lym- 
phocytic infiltrate with necrosis of the myocardial fibers, and 
2) a lymphocytic infiltration without myocardial fiber necro- 
sis. In six patients with both lymphocytic infiltration and 
necrosis of the myocardial fibers, tachyzoites of Toxoplasma 
gondii were seen within these foci. No specific etiologic 
agent could be found in the remaining cases. 
A distinction must be made between the histologicfind- 
ings of AIDS-associated myocarditis versus secondary myo- 
carditis due to known pathogens as well as idiopathic 
myocarditis. In AIDS-associated myocarditis, the histologic 
findings most frequently described to date have been non- 
specific inflammatory infiltrates without myocyte damage 
that, therefore, do not meet the so-called Dallas criteria (25). 
Both an inflammatory infiltrate and myocyte damage or 
necrosis are required for the histologic diagnosis of myocar- 
ditis according to these criteria (25). The significance of this 
distinction in regard to the more prevalent histologic picture 
of AIDS-associated myocarditis has yet to be defined. 
Noninflammatory myocardial necrosis. Two explanations 
can be offered for the presence of myocardial necrosis 
without inflammation in those cases of AIDS that present 
this histologic pattern. One is that necrosis of the myocytes 
can be brought about by virtue of the long-term stress that 
patients with AIDS are subjected to as a result of the tragic 
implications of their disease; the pathway being mediated 
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through prolonged and excessive secretion of catechol- 
amines (26). The other explanation is that because cytomeg- 
alovirus infections can cause necrosis without inflammation, 
it is possible that cytomegalovirus or other viral agents, 
including human immunodeficiency virus, are the precipitat- 
ing cause of the myocardial necrosis. 
A catecholamine-induced myocarditis is a distinct possi- 
bility through repeated transient focal or widespread ische- 
mia as a result of episodes of microvascular spasm (27). 
Factor and Sonnenblick (28) advance this sequence as an 
important pathogenic mechanism in the development of 
certain types of congestive cardiomyopathy. It is not too 
unreasonable then to conjecture that this mechanism could 
also prevail in AIDS-induced myocarditis as an aggravating 
rather than as a sole etiologic factor. 
Endocarditis 
Marantic endocarditis. The most common endocardial 
lesion seen in the studies to date is nonbacterial thrombotic 
bacterial endocarditis-so-called Marantic endocarditis 
(17,19,29). Any of the valves can be involved. Nonbacterial 
thrombotic endocarditis is known to be associated with 
long-term wasting illnesses and malignancies (30), and this 
may be the reason for finding it in AIDS. 
Marantic endocarditis was associated with disseminated 
intravascular coagulation in one patient and systemic embo- 
lization in others (17,19). In the series of Cammarosano and 
Lewis (17), systemic embolization with cerebral infarcts 
occurred in the patient with the vegetations involving the 
mitral valve, and in another with vegetations involving all 
four valves. All the vegetations were friable. Microscopi- 
cally, they consisted of a fribin mesh with few chronic 
inflammatory cells. Neurologic complications in AIDS have 
been reported, and it is possible that embolization was one 
factor in these complications in some of the patients de- 
scribed by Snyder et al. (31). 
Healed bacterial endocarditis. This lesion has also been 
reported, but it probably represents antecedent infection 
rather than an AIDS-associated condition because bacterial 
endocarditis has been reported in those patients with a 
history of intravenous drug abuse. 
Aspergiflus endocarditis. One case of Aspergillus endo- 
carditis was reported in an individual with concomitant 
pulmonary aspergillosis (32). In this patient, a two-dimen- 
sional echocardiogram showed a large vegetation on the 
anterior mitral leaflet, and necropsy revealed scattered myo- 
cardial abscesses containing Aspergillus fumigatus, with 
one large abscess located just beneath the posterior mitral 
leaflet. This was probably the origin of the septic embolus 
that caused the sudden onset of left hemiparesis and aphasia 
in this individual. At no time did this patient have a cardiac 
murmur, positive blood culture for Aspergillus fumigates or 
clinical evidence of cardiac dysfunction. 
Pericarditis 
To date, all the patients with pericardial disease have had 
concomitant involvement of the myocardium. The pericar- 
ditis was usually nonspecific in origin, associated with Kap- 
osi’s sarcoma or due to a pathogen such as Mycobacterium 
tuberculosis and Cvyptococcus (24,33). Many times, pericar- 
dial involvement has been noted clinically by the occurrence 
of pericardial effusion (24,33). Echocardiographic evaluation 
has proved to be an excellent diagnostic tool in detecting 
pericardial effusion and especially in confirming the presence 
of cardiac tamponade (2). This is important to realize, since 
the clinical picture of AIDS may be so overwhelmingly 
dominated by the impact of the opportunistic infections that 
cardiac dysfunction may be easily obscured or unrecog- 
nized. 
Pericardiocentesis may yield a clear-appearing sero- 
sanguineous fluid (2). In many instances, cultures of the 
pericardial fluid of bacteria or fungi have yielded no growth. 
The first case of tuberculous pericarditis was reported by 
D’Cruz et al. (33). The patient had disseminated tuberculosis 
with miliary tubercles in many organs. Both layers of the 
pericardium were studded with various sized tuberculous 
granulomas. Grossly, there was mild dilation and flabbiness 
of all the cardiac chambers, with no evidence of hypertro- 
phy. The microscopic appearance of the myocardium was 
characterized by a moderate, diffuse, nonspecific interstitial 
infiltrate of neutrophils and lymphocytes. There was also a 
patchy dropout of myocardial fibers. During life, pericardio- 
centesis confirmed the echocardiographic diagnosis of peri- 
cardial effusion. Diffuse left ventricular hypokinesia was also 
demonstrated with echocardiography in this patient. 
Cardiomegaly 
Cardiomegaly reported at necropsy has consisted of right 
ventricular hypertrophy or dilation, biventricular dilation or 
four chamber enlargement. 
Right ventricular hypertrophy. The cause of right ven- 
tricular hypertrophy can no doubt be ascribed to the pres- 
sure overload imposed on the right ventricle as a result of 
pulmonary hypertension. Severe or repeated pulmonary 
infections that occur so commonly in AIDS can certainly 
give rise to either acute or chronic pulmonary hypertension. 
The pathophysiologic mechanisms for this are well known. 
Congestive cardiomyopathy. Biventricular or four cham- 
ber dilation is the characteristic postmortem finding in di- 
lated congestive cardiomyopathy. In the series of Anderson 
et al. (23), myocarditis was present in all cases of AIDS- 
related deaths with gross evidence of biventricular dilation. 
Myocarditis was not seen in those cases showing only right 
ventricular dilation, pericardial effusion or cardiac malig- 
nancy (24). 
There is considerable evidence in support of the concept 
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that the syndrome of dilated cardiomyopathy is, at times, a 
postviral disorder (34). This evidence includes the findings 
on endomyocardial biopsy of an inflammatory infiltrate in 
some patients with the clinical features of dilated cardiomy- 
opathy (35,36). Other evidence pointing to a viral origin has 
been the detection of high viral antibody titers (37), viral- 
specific ribonucleic acid (RNA) sequences (37) and apparent 
viral particles. Moreover, several important studies (3g-40) 
have highlighted abnormalities of T cells, especially the 
suppressor T cells, in some cases of dilated cardiomyopathy. 
The presence of a lymphocytic infiltrate in the myocar- 
dium of patients with dilated cardiomyopathy may be ad- 
vanced as an indication of the presence of active myocarditis 
but, as Tazelaar and Billingham (41) have reported, this is 
not necessarily so. Their findings could be construed as 
being the link, albeit weak, in the argument that attempts to 
extrapolate the preceding constellation of evidence into 
documentation of the thesis that human immunodeficiency 
virus itself cannot only induce a myocarditis, but that this 
inflammatory process could result in dilated cardiomyopa- 
thy. 
Although one case alone does not provide adequate 
foundation for a pathogenic mechanism, the isolation of 
human immunodeficiency virus by culture from an endomyo- 
cardial biopsy specimen in an AIDS-associated congestive 
cardiomyopathy lends support to the probability that such a 
mechanism can exist (15). In addition to infectious agents, 
viral or otherwise, dilated cardiomyopathy can be caused by 
cardiotoxins, hypersensitivity reactions and certain dietary 
deficiencies (34). 
Drug-induced cardiomyopathy does not appear to be a 
particularly important factor, and is discussed elsewhere. 
Vitamin deficiency, especially of vitamin B,, is certainly a 
possibility in these severely ill patients. However, although 
vitamin B, deficiency might play a role in AIDS-associated 
dilated cardiomyopathy, the probability is that it is a sec- 
ondary factor, the most likely possibility being that the 
cardiomyopathy is secondary to myocarditis and viral in 
origin (34). As mentioned before, there is much documented 
evidence of myocarditis due to any number of viruses, 
including the Epstein-Barr virus and cytomegalovirus 
(42,43). Immune suppression, as in AIDS, may very well 
increase the likelihood of infection with these known cardio- 
tropic viruses. With regard to human immunodeficiency 
virus itself, more work needs to be done concerning its role 
in the development of an initial myocarditis with the conse- 
quent emergence of dilated cardiomyopathy. 
The postmortem gross findings of dilated cardiomyopa- 
thy in patients with AIDS have included increased heart 
weight, with either biventricular or four chamber dilation 
and a pale-appearing myocardium (24,44). Microscopically, 
these cases have shown evidence of both hypertrophy in 
focal areas, and focal areas of atrophy with diffuse loss of the 
myofibrillar elements and vacuolization of the atrophic 
myocytes (24,44). Focal areas of inflammatory infiltrate have 
been seen containing lymphocytes, histiocytes and necrotic 
myocytes. Electron microscopic studies have revealed loss 
of myofibrils, lipid deposition and an increase in mitochon- 
dria. In the study of Cohen et al. (44), no viral inclusion 
bodies were noted and heart tissue homogenates inoculated 
into neonatal mice intracerebrally, intraperitoneally and 
subcutaneously showed no evidence of viral pathogens. This 
same group also cultured heart tissue on human foreskin 
fibroblasts, WI-38 cells and Hep-2 cells with negative re- 
sults. 
The clinical manifestations of AIDS-associated dilated 
cardiomyopathy are similar to those of dilated cardiomyop- 
athy of any cause. There is, of course, the clinical spectrum 
of congestive heart failure with radiographic evidence of 
cardiomegaly. The echocardiogram is most useful in detect- 
ing global hypokinesia with decreased fractional shortening, 
decreased ejection fraction and dilation of the various car- 
diac chambers with abnormal left ventricular end-diastolic 
and end-systolic dimensions (2,3). On auscultation, nonspe- 
cific abnormalities such as systolic ejection murmurs, gallop 
rhythm and arrhythmias may be present. The electrocardio- 
gram (ECG) is also nonspecific, demonstrating a pattern of 
left ventricular hypertrophy or strain and nonspecific ST-T 
changes. 
Dilated cardiomyopathy has been described in children 
with congenital AIDS (45). In these children, the clinical 
manifestations have included the various stigmata of conges- 
tive heart failure, roentgenologic evidence of cardiomegaly, 
ECG changes consisting of T wave abnormalities and volt- 
age criteria of left ventricular hypertrophy and echocardio- 
graphic evidence initially of left atria1 and left ventricular 
dilation with decreased fractional shortening in association 
with poor septal and posterior wall motion. Over the course 
of 2 years, these abnormalities are followed by evidence of 
increasing right atria1 and right ventricular enlargement, as 
well as tricuspid valve thickening and nodularity. Steinherz 
et al. (25) also cite the development of right axis deviation on 
the ECG in those individuals with evidence of right ventric- 
ular hypertrophy, and advance the probability that these are 
indications of pulmonary hypertension due to repeated pul- 
monary infections (45). In the series of Joshi et al. (46), those 
children who manifested cardiovascular dysfunction during 
the course of their illness presented the following signs and 
symptoms: shortness of breath, easy fatigability, tachypnea, 
sinus tachycardia with gallop rhythm, scattered rales, hep- 
atomegaly, and radiographic evidence of cardiomegaly. 
Vascular Lesions 
Several types of vascular lesions have been described in 
AIDS. These are an arteriopathy, with or without aneurys- 
ma1 formation, a fibrocalcific lesion, endothelial proliferation 
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in association with Kaposi’s sarcoma and thrombotic epi- 
sodes of the coronary artery tree (47). 
Arteriopathy. Joshi et al. (47) reported the occurrence of 
arteriopathy in children with AIDS. In six children who died 
with AIDS, two types of arteriopathy were detected: inflam- 
matory and fibrocalcific. The inflammatory lesion consisted 
of a vasculitis or perivasculitis in the brain in those children 
who had clinical manifestations of AIDS-associated enceph- 
alopathy. The fibrocalcific lesions were described as intimal 
fibrosis with fragmentation of elastic tissue and fibrosis and 
calcification of the media with variable luminal narrowing. 
The fibrocalcific arteriopathy was seen in various organs. 
including the heart, and involved mostly the small- and 
medium-sized arteries, In one case, aneurysms of the right 
coronary artery were seen in association with intraluminal 
thrombosis and myocardial infarction. Death in this instance 
was attributed to myocardial infarction. 
Perivasculitis of the retina demonstrated by ophthalmo- 
scopic examination has been described (48) in both children 
and adults with AIDS. This condition may have the same 
pathogenesis as the inflammatory arterial lesions in the 
myocardium of the patients described by Joshi et al. (47). 
Aneurysm. The three aneurysms that have been de- 
scribed (47) involve a 3 cm segment of the proximal portion 
of the right coronary artery. The aneurysms were fusiform 
and varied in size from 0.6 to 0.8 cm in diameter. All 
contained recent thrombus, and their walls had multiple 
areas of calcification, as well as fragmentation of the elastic 
tissue with.fibrosis of the intima and media. The left coro- 
nary artery had similar fibrocalcific lesions of lesser severity 
and without aneurysmal formation. None of the coronary 
arteries showed any evidence of inflammation or necrosis of 
their walls. 
Fibrocalcific arteriopathy. The tibrocalcific arteriopathy 
described to date (47,49-51) appears to be distinctive and 
separate from Kawasaki’s disease and idiopathic arterial 
calcification of infancy. This conclusion was primarily based 
on clinicopathologic and immunologic features. The patho- 
genesis of fibrocalcific arteriopathy, however, has yet to be 
delineated. The most obvious etiologic factor would appear 
to be the human immunodeficiency virus itself, but there are 
no studies to prove this. It is also possible that the immuno- 
deficient state may be responsible because of the persistent 
and unchallenged antigenic stimulation (47). Because elastic 
tissue degeneration and fragmentation are the initial steps 
before fibrosis and ca!cification occur, there also may be a 
relation to both endogenous and exogenous elastases (52). 
The children studied live up to 40.5 months. The longer 
survival time in these patients may have been sufficient to 
allow development of vascular lesions, so that there is a 
distinct possibility that the arteriopathy described may be 
seen in the future with increasing frequency as longer 
survival rates are obtained. 
Malignancy 
Homosexual individuals show a higher incidence of the 
following types of malignancies: Kaposi’s sarcoma (cuta- 
neous, mucocutaneous, lymph nodes, gastrointestinal tract, 
lung and liver). high grade lymphoma (central nervous 
system, liver and disseminated) (53-57), oropharyngeal 
squamous cancer (58) and cloacogenic carcinoma of the 
rectum (59). The incidence of neoplasia in AIDS has been 
reported to be 3970. Kaposi’s sarcoma is the most common 
neoplasm seen (60-62). 
Two types of malignancies affecting the heart have been 
described in AIDS. These are Kaposi’s sarcoma and malig- 
nant lymphoma (4,5,8,63,64). Again Kaposi’s sarcoma is by 
far the most common. 
Kaposi’s sarcoma. This is a tumor that is said to arise 
from endothelial tissue. Although involvement of the heart in 
AIDS-associated Kaposi’s sarcoma is usually part of a 
widely disseminated process, primary Kaposi’s sarcoma of 
the heart has also been described (63). Nodular sarcomatous 
lesions involving the entire anterior cardiac wall were found 
at necropsy. with the patient manifesting clinically a nonspe- 
cific cardiomegaly on X-ray study, along with sinus tachy- 
cardia and gallop rhythm. Death in this case was attributed 
to “febrile cardiogenic shock.” Primary cardiac Kaposi’s 
sarcoma has also been reported in individuals without AIDS 
(63) but, because of the high incidence of Kaposi’s sarcoma 
in AIDS, the occurrence of the sarcoma in this case is 
probably more than coincidental. 
In the series of Silver et al. (5), at necropsy, 28% (5 of 18 
patients) had cardiac involvement with Kaposi’s sarcoma as 
part of a widely disseminated process. In each of the five 
patients, Kaposi’s sarcoma was found in the subepicardial 
fatty tissue. There was involvement of the adventitia of the 
ascending aorta in three, and of the pulmonary trunk in one. 
There was no narrowing of a coronary artery by external 
compression from the tumor. The survival time in these 
patients ranged from 6 to 22 months, and none had clinical 
manifestations of cardiac dysfunction as delineated by the 
clinical course, ECG changes and chest X-ray film. 
Apparently, the epicardium is a common location for 
Kaposi’s sarcoma because epicardial involvement has been 
reported by several investigators (4,8,17). In the series of 
Cammarosano and Lewis (17), the sarcomatous lesions were 
metastatic and were found on the epicardial surface with or 
without involvement of the underlying myocardium or over- 
lying pericardium. In their one patient with myocardial 
invasion, the sarcoma had infiltrated a small branch of the 
left anterior descending coronary artery. Extensive myocar- 
dial involvement was also seen (17). Again, in all of these 
reports of sarcomatous involvement of the heart, there was 
a paucity of clinical cardiac dysfunction. As Fink et al. (2) 
have stated, the clinical cardiac findings in AIDS are “unob- 
trusive” and need to be searched for. 
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Malignant lymphoma. Malignant lymphomas in AIDS are 
usually high grade with Burkitt-like cells (small and non- 
cleaved) or large cell immunoblastic plasmacytoid types 
(64,65). In the majority of cases, they appear to originate 
from B cells, with most of them displaying a monoclonal 
pattern of immunoglobulin staining. In some cases, the 
Epstein-Barr virus genome has been demonstrated in the 
proliferating cells (65). 
lopathy or arteriopathic lesions were seen. Histologic sec- 
tions of the myocardium contained patchy infiltrates of 
neoplasm composed of plasmacytoid lymphocytic cells that 
resembled the immunoblastic type of non-Hodgkin’s lym- 
phoma. There was also evidence of intense mitotic activity. 
In normal individuals, cell-mediated immune mechanisms 
are quite efficient in eliminating Epstein-Barr virus-trans- 
formed B lymphocytes (66). The immunodeticient patient, be 
it in AIDS or otherwise, is unable to check the continuous 
proliferation of these transformed B lymphocytes. The pro- 
cess can be initiated from multiple clones, and in the 
continuing development of the lymphoma, one of the clones 
could assume a dominant advantage so that a monoclonal 
pattern of the proliferating B lymphocytes could emerge 
(65,66). 
Could there be a common thread in the causation of 
lymphomas in all immunodejicient syndromes? Several the- 
ories have been advanced in this regard. These include 
chronic antigenic stimulation, impaired immunosurveillance, 
reactivation of latent oncogenic herpes-group viruses and, 
perhaps, direct oncogenic effects of immunosuppressant 
drugs (67-71). The direct oncogenic effect of immunosup- 
pressant drugs, however, does not apply to AIDS, but all the 
other theoretical possibilities are worthy of further investi- 
gation. 
Clinical features. The clinical manifestations of lympho- 
matous involvement of the heart, whether associated with 
AIDS or not, may include cardiomegaly, pericardial effu- 
sion, congestive heart failure or progressive heart block (74- 
77). Sudden death is a rare event (76), and at least half of the 
patients have no clinical evidence of cardiac dysfunction. 
Gallium-67 and blood pool isotope studies can aid in the 
diagnosis (78). Tuberculous pericarditis appears as an area of 
uneven uptake surrounding an enlarged cardiac silhouette, 
whereas viral myocarditis or other inflammatory cardiomyop- 
athies show not only a diffusely increased uptake, but also a 
prominent uptake localized within the left ventricle as a 
result of differences in left ventricular wall thickness (79). 
Echocardiography and ECG studies demonstrate nonspe- 
cific findings. 
Toxic Lesions 
The increased incidence of lymphomatous neoplasm in 
immune deficiency states first became noticeable after the 
increased usage of organ transplants (68). As time went on, 
the relation between non-Hodgkin’s lymphoma and AIDS 
became increasingly evident (69,71). Extranodal sites of 
lymphoma are common in patients with AIDS, and meta- 
static involvement of the heart can occur as part of this 
disseminated process (5,55,70-73). 
There is adequate documentation that drugs can induce 
structural changes in the heart and blood vessels with 
resultant dysfunction (80). The morphologic changes in the 
heart could result in myocarditis, cardiomyopathy and en- 
docardial fibrosis. The changes in the blood vessels can be 
expressed by an inflammatory process with or without 
necrosis, hyperplasia of the fibromuscular layer and throm- 
boembolic phenomena. 
Primary lymphoma in the heart is extremely rare. It was 
found in only 5.6% in the Armed Forces Institute of Pathol- 
ogy series of 125 primary malignant tumors of the heart (73). 
Metastatic lymphoma, on the other hand, is much more 
frequent (73). There are two reports (74,75) describing the 
occurrence of primary cardiac lymphoma in AIDS. 
The nonnecrotizing types of vasculitis are a manifestation 
of a delayed hypersensitivity reaction (81), whereas necro- 
tizing drug-related vasculitis is more frequently, related to a 
direct toxic effect. As yet, none of the drugs currently used 
in AIDS have been incriminated in this mechanism. In 
addition, none of the drugs currently utilized in AIDS- 
associated infections or malignancy have any relation to the 
development of endocardial fibrosis or vascular fibromus- 
cular hyperplasia. On the other hand, mural thrombus for- 
mation is common in Adriamycin-related cardiomyopathy 
(82). 
Pathology. Whether primary or secondary, lymphomas Drug-induced cardiomyopathy or myocarditis. This is an 
involving the heart in AIDS are characterized by one of two important aspect of the cardiac complications of AIDS. 
different pathologic patterns. One consists of a diffuse infil- Because myocarditis due to hypersensitivity as well as the 
tration that imparts a large pale appearance to the heart. The allergic type of vasculitis does not require an intact immune 
other pattern involves the epicardium, myocardium and system, this mechanism could prevail in AIDS. In contrast, 
endocardium in the form of focal circumscribed nodules (73- the remaining types of drug-induced morphologic changes 
75). In the two cases of primary cardiac lymphoma reported that involve a mechanism independent of any immunologic 
by Guarner et al. (67) there were focal circumscribed lesions. mediation could occur in AIDS (Sweeney MJ, personal 
Constantino et al. (74) observed that the heart was enlarged communication, 1988). In AIDS, T helper cell function is 
and showed “multiple and well-circumscribed homogeneous altered. Therefore, the ability to orchestrate immune func- 
white, fish-flesh infiltrates in the left posterior and lateral tion is hindered. This can result in uncontrolled hypergam- 
walls as well as in the interventricular septum.” No valvu- maglobulinemia. If the immunoglobulin is of the IgE class, 
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then a type I hypersensitivity reaction could ensue, with 
myocarditis as an expression of this mechanism. Moreover, 
because the T suppressor cells are also capable of altering 
function, a state of hyperreactivity as well as “autoim- 
munity” could result with a high likelihood of expression. 
This type of immune abnormality could lead to reactions 
against self antigens and to chronic inflammatory-like dis- 
eases. It has already been demonstrated that human immu- 
nodeficiency virus-positive patients show high concentra- 
tions of immune complexes in their sera (Sweeney MJ, 
personal communication, 1988). This has the potential for 
causing not only local and systemic inflammatory lesions, 
but also disseminated intravascular coagulation and other 
abnormalities both in valvular tissue and in the blood vessels 
and major organs of the body. 
A direct toxic eJJect is an important mechanism of drug- 
induced myocardial damage. This effect could be manifested 
as an acute or chronic myocarditis, either of which could 
ultimately result in cardiomyopathy. The preceding remarks 
merely emphasize the drug-induced cardiomyopathy or 
myocarditis can become an important aspect of the cardiac 
complications of AIDS and that this possibility should be 
kept in mind. 
Categories of Toxic Drugs Used in AIDS 
There are essentially two broad categories of drugs used 
in the management of AIDS: those that have as their 
objective the treatment of the opportunistic infections them- 
selves or the malignancies that are seen in this syndrome, 
and those that are aimed at the elimination of the human 
immunodeficiency virus itself. 
In addition, there are several important considerations in 
the treatment of AIDS-related opportunistic infections: 1) 
the immune deficiency state itself renders these patients less 
responsive to conventional therapy; 2) combinations of 
infections are often present; 3) prolonged and repeated 
therapeutic regimens are often necessary; and 4) there is a 
high incidence of drug-related toxic reactions in patients 
with AIDS. 
Table 3 lists the pharmaceutical agents that have been or 
are currently being used in treating the various opportunistic 
infections and the etiologic agent against which the drug has 
been used. 
Drug treatment of opportunistic infections. An important 
opportunistic infection in AIDS is caused by Pneumocystis 
carinii. In fact, Pneumocystis carinii pneumonia is the most 
common opportunistic infection in AIDS. It is usually 
treated with sulfamethoxazole-trimethoprim and pentami- 
dine isethionate. The majority of AIDS patients treated for 
P. carinii pneumonia with sulfamethoxazole-trimethoprim 
will develop serious toxic reactions to the drug (83,84). 
However, adverse reactions in the heart have not been 
described to date, whereas when pentamidine isethionate 
was used, orthostatic hypertension was observed, especially 
when intravenous administration was at too rapid a rate 
(85,86). 
There are tM,o important drugs under investigation for the 
treatment of P. carinii pneumonia in those patients who 
cannot tolerate or do not respond to treatment with sulfa- 
methoxazole-trimethoprim and pentamidine isethionate. 
These drugs are dapsone alone or in combination with 
sulfamethoxazole-trimethoprim and eflornithine (difluoro- 
methylornithine). These two drugs do not cause a direct 
toxic effect on the myocardium, but it is conceivable that 
dapsone. because of the methemoglobinemia that can occur 
from its usage, can adversely affect the cardiovascular 
system by virtue of the resultant hypoxemia. Barbarash et 
al. (87) reported the development of a cardiac conduction 
disturbance during infusion with alpha-difluoromethylorni- 
thine (eflornithine). The conduction abnormality consists of 
first degree heart block and sinus bradycardia, progressing to 
complete heart block and finally electromechanical dissoci- 
ation and death. 
Amphotericin B is a highly toxic drug used in the very 
sel’ere case.7 of infections with Cryptococcus neoformans, 
Aspergillus fumigatus, Histoplasmosis capsulatum, Cocci- 
dioides immitis and disseminated Candida albicans. Arrhyth- 
mia, ventricular fibrillation, hypotension. hypertension and 
cardiac arrest have been reported with amphotericin B. The 
drugs listed for the remaining etiologic agents in Table 3 have 
not been incriminated as having any adverse cardiac effects. 
Chemotherapy. The role of chemotherapy in AIDS- 
associated Kaposi’s sarcoma is purely palliative. As yet, 
there are no clinical data to suggest that this therapeutic 
modality will improve survival rates in these patients (88). 
Despite this guarded perception of its efficacy, chemother- 
apy, nevertheless, is currently being used in the management 
of AIDS-associated Kaposi’s sarcoma, with the main drugs 
being the vinca alkaloids (vincristine sulfate and vinblastine 
sulfate). Doxorubicin (Adriamycin) in combination with vin- 
blastine and bleomycin has also been used in AIDS- 
associated Kaposi’s sarcoma. Myocarditis is a well docu- 
mented complication of doxorubicin (89). Hypertension, 
unexpected myocardial infarction and cerebrovascular acci- 
dents have been reported with vinblastine. 
Extensive data have been accumulated on the usage of 
alpha-interferon in AIDS-associated Kaposi’s sarcoma. The 
adverse cardiovascular effects of this antiviral, antiprolifera- 
tive and immunomodulatory agent are hypotension, hyper- 
tension and tachycardia (90-92). 
Various protocols are under investigation at this time for 
the treatment of AIDS-related non-Hodgkin’s lymphoma. 
The incidence of adverse cardiac effects in these protocols 
is, as yet, unknown, pending publication of the completed 
studies. 
Treatment of immunodeticiency virus. The ideal thera- 
peutic approach in the management of AIDS would appear 
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Table 3. Opportunistic Infections in AIDS 
Etiologic Agent Pharmaceutical Agent 
Sulfamethoxazole-trimethoprim, 
pentamidine isethionate, 
dapsone, 
Cardiac Reactions 
Pneumocystis carinii None reported 
None reported 
Hypoxemia secondary to hemolysis and 
methemoglobinemia 
Hypoxemia secondary to anemia from bone 
marrow depression 
Arrhythmia, ventricular fibrillation, hypotension 
hypertension, cardiac arrest 
None reported 
None reported 
None reported 
None reported 
No clinical experience yet 
Ctyptococcus neoformans 
Mycobacterium 
tuberculosis 
M. avium-intracellulare 
Aspergihs fumigatus 
Histoplasma capsulatum 
Candida immitis 
C. albicans (disseminated) 
C. albicans (esophageal) 
C. albicans (oral) 
eflornithine 
(alpha-difluoromethylornithine) 
Amphotericin B, 
flucytosine 
Streptomycin, 
soniazide, 
nifampin 
No clearly active agent available 
Amphotericin B 
Amphotericin B 
Amphotericin B 
Amphotericin B 
Retoconazole 
Clotrimazole or 
nystatin or 
ketoconazole 
Toxoplasma gondii 
Cytomegalovirus 
Herpes simplex and zoster 
Sulfadiazine and pyrimethamine with 
leucovorin 
DHPG (ganciclovir) 
Acyclovir 
As above 
As above 
As above 
As above 
None reported 
None reported 
None reported 
None reported 
None reported 
None reported 
None reported 
DHPG = (I ,3-dihydroxy-2-propoxymethyl) guanine. 
to be the complete eradication of the human immunodefi- 
ciency virus. This approach is, of course, dependent on the 
unproved assumption that the natural and fatal progression 
of AIDS is a result of replication of the human immunode- 
ficiency virus, beginning with the initial inoculum. Based on 
this assumption, two avenues of approach are currently 
under investigation. These include treatment with immuno- 
modulating agents and antiviral therapy. 
Foremost among the immunomodulator agents is inter- 
leukin 2 (88). This is a potent lymphokine that activates the 
effector agents of the immune response (B cells, cytotoxic T 
lymphocytes and natural killer cells). Future use of this 
agent is highly doubtful because of discouraging results so 
far. However, it is mentioned because it may be used in 
future clinical trials in combination with other agents and, 
perhaps, be responsible for adverse cardiovascular effects 
that are, as yet, unidentified. 
A number of antiviral agents have been identified as 
being capable of inhibiting replication of human immunode- 
ficiency virus in vitro. Most have in common the ability to 
inhibit the reverse transcriptase enzyme, which plays an 
important role in the life cycle of retroviruses. Azidothymi- 
dine (AZT), a nucleoside analogue, has emerged as the most 
promising of these agents. In a Phase 1 clinical trial, no 
adverse cardiovascular effects were noted. Richman et al. 
(93) also failed to note any adverse cardiac effects (93); their 
study, however, concentrated on the hematologic toxicity, 
and the study design, like that of Fischle et al. (94), failed to 
focus specifically on the heart. The incidence of drug- 
induced cardiac complications will most certainly change as 
newer agents are added to the therapeutic armamentarium. 
I am grateful for the excellent secretarial support provided by Nilah Franklin. 
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